Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2010124393) ANTICANCER AGENT COMPRISING A YATAPOXVIRUS MUTANT AND USES THEREOF
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/124393 International Application No.: PCT/CA2010/000674
Publication Date: 04.11.2010 International Filing Date: 30.04.2010
IPC:
A61K 35/76 (2006.01) ,A61P 35/00 (2006.01) ,C12N 7/01 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35
Medicinal preparations containing material or reaction products thereof with undetermined constitution
66
Materials from micro-organisms
76
Viruses
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35
Antineoplastic agents
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7
Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
01
Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material
Applicants:
NATIONAL RESEARCH COUNCIL OF CANADA [CA/CA]; 1200 Montreal Road M-58, EG-19 Ottawa, Ontario K1A 0R6, CA (AllExceptUS)
JOHNSTON, James [CA/CA]; CA (UsOnly)
WANG, Gen [CA/CA]; CA (UsOnly)
Inventors:
JOHNSTON, James; CA
WANG, Gen; CA
Agent:
MEE, Trevor R.; KIRBY EADES GALE BAKER Box 3432, Station D Ottawa, Ontario K1P 6N9, CA
Priority Data:
61/174,17430.04.2009US
Title (EN) ANTICANCER AGENT COMPRISING A YATAPOXVIRUS MUTANT AND USES THEREOF
(FR) AGENT ANTICANCÉREUX COMPRENANT UN MUTANT DE YATAPOXVIRUS ET SES UTILISATIONS
Abstract:
(EN) Disclosed are mutant and recombinant Yatapoxviruses suitable for use as a therapeutic agent, in particular, an agent for use in the prophylaxis or treatment of cancer Also disclosed are expression cassettes and constructs for the production of said agent, methods for the production of said agent, and methods of medical treatment involving said agent.
(FR) L'invention porte sur des Yatapoxvirus mutants et recombinants appropriés pour une utilisation en tant qu'agent thérapeutique, en particulier, sur un agent pour une utilisation dans la prophylaxie ou le traitement d'un cancer. L'invention porte également sur des cassettes d'expression et des produits de construction pour la production dudit agent, sur des procédés de production dudit agent, et sur des procédés de traitement médical mettant en jeu ledit agent.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)